glp-1 alcohol Anti-Obesity Rx and and Substance Use Disorders How GLP-1 Drugs Are Impacting

Are GLP-1 Medications Worth the Cost

Long-term inflammation is linked to: Type 2 diabetes Heart disease Fatty liver (NAFLD/NASH) Obesity Autoimmune and gut disorders Experts believe metabolic inflammation is a root cause of insulin resistance and poor cardiovascular outcomes

A scoping review of GLP-1 receptor agonists: are they associated with increased gastric contents, regurgitation, and aspiration events

Two-Year Effects of Semaglutide in Adults with Overweight or Obesity: the STEP 5 Trial

Only in the case of liraglutide did the comparator medications include sitagliptin and exenatide

A poll released Friday by KFF found that about 1 in 8 adults say they are currently taking a GLP-1 drug to treat a chronic disease, for weight loss or both an increase of 6% since May 2024